Siponimod
Common brands: Mayzent, Vitamin D, Baclofen, Baclofen (Intrathecal), Fleqsuvy
Top reporter: Novartis Pharmaceuticals Corporation
Sphingosine 1-phosphate Receptor Modulator [EPC]Provitamin D2 Compound [EPC]gamma-Aminobutyric Acid-ergic Agonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Potassium Channel Blocker [EPC]
8,797
Total Reports
4,896
Serious Reports
206
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.34%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Siponimod.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | FATIGUE | 989 | |
| 2 | HEADACHE | 888 | |
| 3 | DIZZINESS | 664 | |
| 4 | GAIT DISTURBANCE | 532 | |
| 5 | MULTIPLE SCLEROSIS RELAPSE | 532 | |
| 6 | FALL | 506 | |
| 7 | MULTIPLE SCLEROSIS | 484 | |
| 8 | DRUG INEFFECTIVE | 417 | |
| 9 | LYMPHOCYTE COUNT DECREASED | 415 | |
| 10 | NAUSEA | 415 | |
| 11 | PRODUCT DOSE OMISSION ISSUE | 391 | |
| 12 | URINARY TRACT INFECTION | 371 | |
| 13 | COVID-19 | 365 | |
| 14 | ASTHENIA | 356 | |
| 15 | PAIN | 339 | |
| 16 | BALANCE DISORDER | 312 | |
| 17 | HYPOAESTHESIA | 308 | |
| 18 | MALAISE | 306 | |
| 19 | MEMORY IMPAIRMENT | 305 | |
| 20 | FEELING ABNORMAL | 291 | |
| 21 | HYPERTENSION | 287 | |
| 22 | WHITE BLOOD CELL COUNT DECREASED | 274 | |
| 23 | VISUAL IMPAIRMENT | 269 | |
| 24 | PAIN IN EXTREMITY | 254 | |
| 25 | MUSCULAR WEAKNESS | 243 | |
| 26 | HEART RATE DECREASED | 242 | |
| 27 | PERIPHERAL SWELLING | 240 | |
| 28 | DYSPNOEA | 238 | |
| 29 | LYMPHOPENIA | 225 | |
| 30 | VISION BLURRED | 225 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.